Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Jennifer Cooper

Concepts (64)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lupus Nephritis
7
2024
52
2.480
Why?
Cyclophosphamide
5
2024
217
1.780
Why?
Immunosuppressive Agents
6
2024
646
1.490
Why?
Mycophenolic Acid
2
2018
77
0.750
Why?
Rheumatology
4
2022
88
0.700
Why?
Lupus Erythematosus, Systemic
3
2023
219
0.540
Why?
Glucocorticoids
2
2022
532
0.500
Why?
Guideline Adherence
1
2018
490
0.470
Why?
Kidney
4
2024
1188
0.400
Why?
Lupus Vasculitis, Central Nervous System
1
2024
7
0.240
Why?
Neurofilament Proteins
1
2024
34
0.230
Why?
Glial Fibrillary Acidic Protein
1
2024
79
0.230
Why?
Arthritis, Juvenile
1
2022
42
0.200
Why?
Nephrology
1
2022
48
0.200
Why?
Adolescent
8
2024
17831
0.200
Why?
Remission Induction
2
2022
233
0.200
Why?
Microscopic Polyangiitis
1
2021
12
0.200
Why?
Granulomatosis with Polyangiitis
1
2021
41
0.190
Why?
Glomerulonephritis
1
2021
45
0.190
Why?
Rituximab
1
2021
150
0.180
Why?
Skin Diseases
1
2022
122
0.180
Why?
Child
11
2024
18404
0.180
Why?
Vasculitis
1
2021
66
0.180
Why?
Consensus
2
2022
537
0.180
Why?
Immunologic Factors
1
2021
220
0.170
Why?
Cognitive Dysfunction
1
2023
284
0.160
Why?
Autoimmune Diseases
1
2021
382
0.150
Why?
Anti-Asthmatic Agents
1
2021
349
0.140
Why?
Acute Kidney Injury
1
2022
637
0.130
Why?
Feasibility Studies
1
2018
739
0.130
Why?
Biomarkers
1
2024
3408
0.120
Why?
Pilot Projects
1
2018
1372
0.110
Why?
Cohort Studies
2
2022
4894
0.110
Why?
Humans
13
2024
114623
0.100
Why?
Female
7
2024
59466
0.100
Why?
Registries
1
2018
1767
0.090
Why?
Practice Patterns, Physicians'
1
2017
1177
0.080
Why?
Treatment Outcome
2
2021
9084
0.080
Why?
Asthma
1
2021
2029
0.080
Why?
Prospective Studies
1
2018
6217
0.070
Why?
Male
6
2024
55554
0.070
Why?
Neuroglia
1
2024
150
0.050
Why?
T-Lymphocytes, Helper-Inducer
1
2023
127
0.050
Why?
Atrophy
1
2022
152
0.050
Why?
Adult
4
2024
30528
0.050
Why?
T-Lymphocyte Subsets
1
2023
383
0.050
Why?
Granuloma
1
2021
83
0.040
Why?
Fibrosis
1
2022
453
0.040
Why?
Renal Dialysis
1
2022
374
0.040
Why?
Eosinophils
1
2021
278
0.040
Why?
Bone Density
1
2022
432
0.040
Why?
B-Lymphocytes
1
2023
766
0.040
Why?
Rheumatologists
1
2017
12
0.040
Why?
Nephrologists
1
2017
12
0.040
Why?
Case-Control Studies
1
2024
3003
0.040
Why?
Retrospective Studies
2
2024
12542
0.030
Why?
Neurons
1
2024
1279
0.030
Why?
Antibodies, Monoclonal, Humanized
1
2021
663
0.030
Why?
Pediatricians
1
2017
122
0.030
Why?
Health Care Surveys
1
2017
539
0.030
Why?
Models, Biological
1
2021
1620
0.030
Why?
Middle Aged
2
2024
26719
0.030
Why?
Young Adult
1
2024
10455
0.020
Why?
United States
1
2024
12176
0.020
Why?
Cooper's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)